The Europe Medical Biomimetics Market would witness market growth of 6.4% CAGR during the forecast period (2023-2029).
The growth of the medical biomimetics market can be attributed to the increasing prevalence of heart and dental diseases. As medical biomimetics can be used to reconstruct broken bones, their usage with the increasing number of road accidents is expected to increase. Additionally, dental biomimetics is utilized in dental bone graft procedures to enhance the density and volume of the jaw in regions where bone loss has taken place.
Dental biomimetic is a dental procedure utilized for tooth replacement and jaw reconstruction in preparation for denture placement. The increasing incidence of dental conditions like dental caries and periodontal diseases, such as gingivitis and periodontitis, drives the need for medical biomimetics.
Central and Eastern Europe has higher death rates from ischemic heart disease (IHD) and stroke than Northern, Southern, and Western Europe. Around 49 million people in the EU and 85 million in Europe are estimated to have had CVD in 2015. Of all the behavioral risk factors, diet had the greatest impact on the likelihood of CVD mortality and CVD DALYs at the population level in Europe. The medical risk factor with the greatest effect is high systolic blood pressure, also known as high blood pressure (BP). The robust prevalence of CVD and the strong presence of a technologically advance healthcare system will raise the adoption of medical biomimetics for their treatment, thus propelling the market growth in the region.
The Germany market dominated the Europe Medical Biomimetics Market by Country in 2022, and would continue to be a dominant market till 2029; thereby, achieving a market value of $3,692.1 Million by 2029. The UK market is anticipated to grow at a CAGR of 5.6% during (2023 - 2029). Additionally, The France market would exhibit a CAGR of 7.2% during (2023 - 2029).
Based on Disease Type, the market is segmented into Dental, Orthopedic, Ophthalmology, Cardiovascular and Others. Based on Application, the market is segmented into Wound Healing, Tissue Engineering, Drug Delivery and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Worldwide Medical Biomimetics Market is Projected to reach USD 57.7 Billion by 2029, at a CAGR of 6.9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Zimmer Biomet Holdings, Inc., BioHorizons, Inc. (Henry Schein, Inc.), SynTouch Inc., CorNeat Vision Ltd., Osteopore International Pte Ltd, Curasan, Inc., Otsuka Medical Devices Co., Ltd. (Otsuka Holdings Co. Ltd.), Swedish Biomimetics 3000 ApS, Keystone Dental Group and Blatchford Limited.
By Disease Type
By Application
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
